$BSX is under pressure after investors reacted sharply to the latest developments surrounding the company.

The sell-off has traders questioning whether this is a temporary setback or a sign that Boston Scientific’s growth story is facing bigger challenges.

Is $BSX a dip-buying opportunity, or is more downside coming?